REC — Recordati Industria Chimica E Farmaceutica SpA Income Statement
0.000.00%
Last trade - 00:00
- €10.11bn
- €11.70bn
- €2.08bn
- 89
- 16
- 97
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,482 | 1,449 | 1,580 | 1,853 | 2,082 |
Cost of Revenue | |||||
Gross Profit | 1,045 | 1,042 | 1,152 | 1,287 | 1,423 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,017 | 980 | 1,090 | 1,411 | 1,523 |
Operating Profit | 465 | 469 | 490 | 442 | 560 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 444 | 456 | 463 | 401 | 491 |
Provision for Income Taxes | |||||
Net Income After Taxes | 369 | 355 | 386 | 312 | 389 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 369 | 355 | 386 | 312 | 389 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 369 | 355 | 386 | 312 | 389 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.77 | 1.71 | 1.9 | 1.58 | 1.72 |
Dividends per Share |